Chemours Co (CC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5B 5B 7.5B Q3 '16: 5.4B Q4 '16: 5.4B Q1 '17: 5.5B Q2 '17: 5.7B Q3 '17: 5.9B Q4 '17: 6.2B Q1 '18: 6.5B Q2 '18: 6.7B Q3 '18: 6.7B Q4 '18: 6.6B Q1 '19: 6.3B Q2 '19: 5.9B Q3 '19: 5.6B Q4 '19: 5.5B Q1 '20: 5.5B Q2 '20: 5.1B Q3 '20: 5B Q4 '20: 5B Q1 '21: 5.1B Q2 '21: 5.7B Q3 '21: 6.1B Q4 '21: 6.3B Q1 '22: 6.7B Q2 '22: 6.9B Q3 '22: 7B Q4 '22: 6.8B Q1 '23: 6.6B Q2 '23: 6.3B Q3 '23: 6B Q4 '23: 6B Q1 '24: 5.9B Q2 '24: 5.8B Q3 '24: 5.8B Q4 '24: 5.8B Q1 '25: 5.8B Q2 '25: 5.8B Q3 '25: 5.8B Q4 '25: 5.8B Q1 '26: 5.8B Q2 '26: 5.8B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 700M 1.4B 2.1B Q3 '16: 1B Q4 '16: 1.1B Q1 '17: 1.3B Q2 '17: 1.4B Q3 '17: 1.6B Q4 '17: 1.7B Q1 '18: 1.9B Q2 '18: 2B Q3 '18: 2.1B Q4 '18: 2B Q1 '19: 1.7B Q2 '19: 1.5B Q3 '19: 1.3B Q4 '19: 1.1B Q1 '20: 1.1B Q2 '20: 941M Q3 '20: 904M Q4 '20: 1.1B Q1 '21: 1.1B Q2 '21: 1.1B Q3 '21: 1.3B Q4 '21: 1.4B Q1 '22: 1.6B Q2 '22: 1.8B Q3 '22: 1.8B Q4 '22: 1.6B Q1 '23: 1.5B Q2 '23: 1.4B Q3 '23: 1.3B Q4 '23: 1.3B Q1 '24: 1.2B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1B Q4 '25: 903M Q1 '26: 879M Q2 '26: 887M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-800M -400M 0 400M 800M 1.2B Q3 '16: 151M Q4 '16: 7M Q1 '17: 106M Q2 '17: 285M Q3 '17: 288M Q4 '17: 746M Q1 '18: 893M Q2 '18: 1B Q3 '18: 1.1B Q4 '18: 995M Q1 '19: 792M Q2 '19: 607M Q3 '19: 408M Q4 '19: -51M Q1 '20: -45M Q2 '20: -117M Q3 '20: -117M Q4 '20: 219M Q1 '21: 215M Q2 '21: 257M Q3 '21: 395M Q4 '21: 609M Q1 '22: 747M Q2 '22: 882M Q3 '22: 908M Q4 '22: 578M Q1 '23: 489M Q2 '23: -88M Q3 '23: -316M Q4 '23: -237M Q1 '24: -328M Q2 '24: 108M Q3 '24: 64M Q4 '24: 71M Q1 '25: 12M Q2 '25: -428M Q3 '25: -336M Q4 '25: -372M Q1 '26: -396M Q2 '26: -290M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 2B 4B 6B Q4 '17: 4.4B Q1 '18: 4.6B Q2 '18: 4.7B Q3 '18: 4.7B Q4 '18: 4.7B Q1 '19: 4.6B Q2 '19: 4.4B Q3 '19: 4.3B Q4 '19: 4.5B Q1 '20: 4.4B Q2 '20: 4.2B Q3 '20: 4.1B Q4 '20: 3.9B Q1 '21: 4B Q2 '21: 4.5B Q3 '21: 4.8B Q4 '21: 5B Q1 '22: 5.1B Q2 '22: 5.1B Q3 '22: 5.2B Q4 '22: 5.2B Q1 '23: 5.1B Q2 '23: 4.9B Q3 '23: 4.8B Q4 '23: 4.7B Q1 '24: 4.6B Q2 '24: 4.7B Q3 '24: 4.7B Q4 '24: 4.6B Q1 '25: 4.7B Q2 '25: 4.8B Q3 '25: 4.8B Q4 '25: 4.9B Q1 '26: 4.9B Q2 '26: 4.9B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-1B -500M 0 500M 1B 1.5B Q3 '16: 626M Q4 '16: 594M Q1 '17: 599M Q2 '17: 693M Q3 '17: 607M Q4 '17: 640M Q1 '18: 795M Q2 '18: 954M Q3 '18: 1.2B Q4 '18: 1.1B Q1 '19: 900M Q2 '19: 563M Q3 '19: 509M Q4 '19: 650M Q1 '20: 738M Q2 '20: 843M Q3 '20: 854M Q4 '20: 807M Q1 '21: 802M Q2 '21: 947M Q3 '21: 959M Q4 '21: 814M Q1 '22: 777M Q2 '22: 812M Q3 '22: 802M Q4 '22: 755M Q1 '23: 629M Q2 '23: 405M Q3 '23: 235M Q4 '23: 556M Q1 '24: 390M Q2 '24: -297M Q3 '24: -289M Q4 '24: -633M Q1 '25: -455M Q2 '25: 258M Q3 '25: 265M Q4 '25: 264M Q1 '26: 332M Q2 '26: 397M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-1.1B -700M -350M 0 350M 700M 1.1B Q3 '16: 264M Q4 '16: 256M Q1 '17: 281M Q2 '17: 385M Q3 '17: 258M Q4 '17: 229M Q1 '18: 351M Q2 '18: 453M Q3 '18: 675M Q4 '18: 642M Q1 '19: 371M Q2 '19: 36M Q3 '19: -30M Q4 '19: 169M Q1 '20: 284M Q2 '20: 452M Q3 '20: 544M Q4 '20: 540M Q1 '21: 581M Q2 '21: 720M Q3 '21: 712M Q4 '21: 537M Q1 '22: 454M Q2 '22: 494M Q3 '22: 479M Q4 '22: 448M Q1 '23: 337M Q2 '23: 117M Q3 '23: -67M Q4 '23: 186M Q1 '24: 9M Q2 '24: -693M Q3 '24: -675M Q4 '24: -993M Q1 '25: -797M Q2 '25: -54M Q3 '25: -12M Q4 '25: 51M Q1 '26: 154M Q2 '26: 218M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q3 '14: 181M Q1 '15: 181M Q2 '15: 181M Q3 '15: 181M Q1 '16: 181.5M Q2 '16: 181.5M Q3 '16: 183.5M Q1 '17: 189.1M Q2 '17: 191.1M Q3 '17: 191.6M Q1 '18: 188.3M Q2 '18: 183.8M Q3 '18: 181.9M Q1 '19: 172.1M Q2 '19: 166.9M Q3 '19: 165.1M Q1 '20: 165.3M Q2 '20: 165.4M Q3 '20: 166.6M Q1 '21: 169.1M Q2 '21: 170.2M Q3 '21: 169M Q1 '22: 163.6M Q2 '22: 159.7M Q3 '22: 157.9M Q1 '23: 151.2M Q2 '23: 149.1M Q3 '23: 150.2M Q1 '24: 150.1M Q2 '24: 150.1M Q3 '24: 149.7M Q1 '25: 149.9M Q2 '25: 150.2M Q3 '25: 150.8M Q1 '26: 150.8M Q2 '26: 151.2M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '16: 0.81 Q4 '16: 0.03 Q1 '17: 0.54 Q2 '17: 1.48 Q3 '17: 1.45 Q4 '17: 3.90 Q1 '18: 4.69 Q2 '18: 5.38 Q3 '18: 5.81 Q4 '18: 5.43 Q1 '19: 4.40 Q2 '19: 3.44 Q3 '19: 2.39 Q4 '19: -0.36 Q1 '20: -0.30 Q2 '20: -0.72 Q3 '20: -0.72 Q4 '20: 1.33 Q1 '21: 1.29 Q2 '21: 1.53 Q3 '21: 2.34 Q4 '21: 3.62 Q1 '22: 4.48 Q2 '22: 5.35 Q3 '22: 5.60 Q4 '22: 3.56 Q1 '23: 3.09 Q2 '23: -0.69 Q3 '23: -2.13 Q4 '23: -1.60 Q1 '24: -2.20 Q2 '24: 0.71 Q3 '24: 0.41 Q4 '24: 0.45 Q1 '25: 0.06 Q2 '25: -2.86 Q3 '25: -2.24 Q4 '25: -2.47 Q1 '26: -2.63 Q2 '26: -1.91 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.